-
Strengths and limitations of PSMA PET: When to use it (and when not to)
November 26, 2021The prostate-specific membrane antigen positron emission tomography (PSMA PET) scan is the (relatively) new kid on the block in...
0 -
Radioligand therapy: multidisciplinary collaboration for health system readiness
September 13, 2021By the European Society for Medical Oncology (ESMO) team Join the EMUC21 session ‘Radioligand therapy: multidisciplinary collaboration for health...
-
EMUC20: Highlights in GU cancers
November 13, 2020Active surveillance should be considered the first treatment for prostate cancer in order to ensure the best quality of...
-
Early detection of prostate cancer: a multidisciplinary look
November 15, 2019Using the fortieth anniversary of the discovery of PSA as a starting point, EMUC19 began with a session on...
-
The future of good evidence gathering for PCa
November 9, 2018New approaches to clinical trials can lead to more successful results in the challenging near future. Parallel, comparative studies...
-
PCa management essentials opens EMUC’s 10th year
November 9, 2018Throughout a decade, the European Multidisciplinary Congress on Urological Cancers (EMUC) has established its reputation as the leading platform...
-
EMUC18: Costs and optimal PCa care- Finding the crucial balance
June 26, 2018Across Europe the debate has begun on how to deliver uniform and quality care for prostate cancer (PCa) patients...
